<DOC>
	<DOCNO>NCT02247869</DOCNO>
	<brief_summary>Prospective , multicenter , Phase II trial design ass whether intensification ABVD ( dd-ABVD ) feasible improve outcome patient early stage Hodgkin Lymphoma .</brief_summary>
	<brief_title>Dose-dense ABVD First Line Therapy Early Stage Unfavorable Hodgkin 's Lymphoma</brief_title>
	<detailed_description>Dose-density show important factor complete remission rate longterm survival lymphoma . The aim study find whether intensification ABVD ( dd-ABVD ) feasible improve outcome patient early stage Hodgkin Lymphoma . In view emerge data role early PET define prognosis Hodgkin Lymphoma patient , percentage FDG-PET ( fluorodeoxyglucose positron emission tomography ) negativity two cycle choose parameter evaluate dd-ABVD activity .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<criteria>Age 1870 year Histologically confirm Hodgkin Lymphoma stage I , II unfavorable accord EORTC ( European Organisation Research Treatment Cancer ) criterion , exclusion stage II B bulky . Previously untreated ECOG ( Eastern Cooperative Oncology Group ) performance status 0 2 Staging FDGPET ( fluorodeoxyglucose positron emission tomography ) Written informed consent Adequate liver renal function ( total serum bilirubin &lt; 2.5 x ULN , AST/SGOT and/or ALT/SGPT ≤ 2.5 x upper limit normal ( ULN ) ≤ 5.0 x ULN transaminase elevation due disease involvement , serum creatinine &lt; 2.5 x ULN ) Concomitant cardiac , pulmonary , neurologic , psychiatric metabolic severe disease . Uncontrolled diabetes mellitus ( fast glucose level 200mg/dl ) Other prior malignancy except adequately treat basal cell carcinoma , squamous cell carcinoma skin , carcinoma situ cervix , carcinoma situ breast cancer patient diseasefree ≥ 3 year Patients known history HIV seropositivity Active HCV infection ( PCR + ; AST &gt; 1.52x UN ) Woman pregnant breast feeding . Fertile patient willing use effective contraception study 3 month end treatment . Women childbearing potential ( WOCBP ) define sexually mature woman undergone hysterectomy naturally postmenopausal least 12 consecutive month . Negative pregnancy test baseline require ( serum β HCG ) . Male patient whose sexual partner ( ) WOCBP willing use effective contraception study 3 month end treatment Nodular lymphocyte prevalence histological subtype</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>HL</keyword>
	<keyword>Hodgkin Lymphoma</keyword>
	<keyword>First line therapy</keyword>
</DOC>